Latest ""
FDA rejects psychedelic MDMA as treatment for PTSD
MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to higher military suicide rates.
By Matthew Perrone
Veterans push for psychedelic therapy, but MDMA application struggles
Veterans have spent years lobbying for the use of psychedelic drugs to treat PTSD, but a critical review of MDMA has put the therapy's approval in doubt.
By Matthew Perrone
Opinion
MDMA-assisted therapy could save veterans and families. Like mine.
Our guest opinion writer, a military spouse, argues that the U.S. government should allow the use of MDMA to treat post-traumatic stress disorder.
By Elaine Brewer
Pentagon didn’t adequately track funds sent to Chinese research labs
Investigators found seven awards, sub-awards or fee-for-service agreements from the Army for research that involved potential enhancement of pathogens.
By Zamone Perez
FDA advisory panel votes against psychedelic therapy to treat PTSD
Panelists said they believe MDMA-assisted therapy is effective, but outstanding questions gave them pause in recommending its use to treat PTSD.
By Zamone Perez